Dr. Nicholas J. Damico, MD

Dr. Damico practices at MyMichigan Medical Center Saginaw in Saginaw, Michigan, part of MyMichigan Health.

Dr. Damico's NPI, 1700233228, was assigned on May 16, 2016. Dr. Damico holds Michigan license 4301503995.

Dr. Damico's primary practice is MyMichigan Medical Center Saginaw, at 800 S Washington Avenue, Saginaw, MI 48601 in Saginaw County. The practice phone is (989) 776-8000.

Dr. Damico's primary practice is MyMichigan Medical Center Saginaw in Saginaw, Michigan, part of MyMichigan Health. Dr. Damico is also affiliated with Covenant Medical Center Harrison. The medical group on file is MyMichigan Medical Center Midland. Dmand AI also links Dr. Damico to 3 more hospitals, 4 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Damico practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Damico's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Damico is licensed in Michigan.

CMS data shows 1,300 Medicare services from Dr. Damico across 17 procedure codes in 2024, for 183 Medicare patients. Medicare paid $93,905 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 183 Medicare patients who saw Dr. Damico in 2024. The largest group is 75 to 84, with 80 patients. 75% of them have cancer, and 75% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Damico's median patient age at 75, with 40% women.

In 2024, Dr. Damico wrote 177 Medicare Part D claims for 76 patients. 97% of them were for generic drugs. CMS names the drug for 103 of them, across 3 drugs with 11 or more claims each, at $999 in total drug cost. In 2023, CMS named 112 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Damico for performance year 2024, reported as part of a group. Dr. Damico accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Damico as offering telehealth.

Dmand AI links 11 papers to Dr. Damico, published from 2019 to 2022. 2021 was the busiest year, with 3. The most frequent topics are Pain Measurement, Radiotherapy, Intensity-Modulated and Vulvar Lichen Sclerosus. Dr. Damico has published most often in Int J Part Ther. Dr. Damico's most frequent co-authors are Aashish D. Bhatt, MD, Michael Z. Kharouta, MD and Mitchell Machtay, MD.

CMS Open Payments shows 3 general payments to Dr. Damico from 3 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Tactile Systems Technology Inc paid the most, $120.